A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms with Switchover, Pilot Study to Evlaluate the Efficacy and Safety of Intravenous Abatracept in Treamtne Resistant Nephrotic Syndrom (Focal Sebmental Glomerulosclerosis/Minimal Cha

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2016 - June 30, 2020